2024

• Maher, N., Danaei Mehr, H., Cong, C., Adegoke, N., Vergara Correa, I., Liu, S., Scolyer, R. (2024). Weakly supervised deep learning image analysis can differentiate melanoma from naevi on haematoxylin and eosin-stained histopathology slides. Journal of the European Academy of Dermatology and Venereology. [More Information]

2023

• Adegoke, N., Gide, T., Mao, Y., Quek, C., Patrick, E., Carlino, M., Lo, S., Menzies, A., Esteves Domingues Pires da Silva, I., Vergara Correa, I., Long, G., Scolyer, R., Wilmott, J. (2023). Classification of the tumor immune microenvironment and associations with outcomes in patients with metastatic melanoma treated with immunotherapies. Journal for ImmunoTherapy of Cancer, 11(10). [More Information]
• Mao, Y., Gide, T., Adegoke, N., Quek, C., Maher, N., Potter, A., Patrick, E., Saw, R., Thompson, J., Spillane, A., Shannon, K., Carlino, M., Lo, S., Menzies, A., Da Silva, I., Long, G., Scolyer, R., Wilmott, J. (2023). Cross‑platform comparison of immune signatures in immunotherapy‑treated patients with advanced melanoma using a rank‑based scoring approach. Journal of Translational Medicine, 21(Green Open Access), Article 257-16 pages. [More Information]
• Gide, T., Paver, E., Yaseen, Z., Maher, N., Adegoke, N., Menzies, A., Esteves Domingues Pires da Silva, I., Wilmott, J., Long, G., Scolyer, R. (2023). Lag-3 expression and clinical outcomes in metastatic melanoma patients treated with combination anti-lag-3 + anti-PD-1-based immunotherapies. OncoImmunology, 12(1), 2261248. [More Information]

2022

• Attrill, G., Lee, H., Tasker, A., Adegoke, N., Ferguson, A., Esteves Domingues Pires da Silva, I., Saw, R., Thompson, J., Palendira, M., Long, G., Ferguson, P., Scolyer, R., Wilmott, J. (2022). Detailed spatial immunophenotyping of primary melanomas reveals immune cell subpopulations associated with patient outcome. Frontiers in Immunology, 13. [More Information]